Gastrointestinal perforation medical therapy

Revision as of 20:20, 8 January 2018 by Medhat (talk | contribs)
Jump to navigation Jump to search


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohammed Abdelwahed M.D[2]

Gastrointestinal perforation Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating gastrointestinal perforation from other diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

X-Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Gastrointestinal perforation medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Gastrointestinal perforation medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Gastrointestinal perforation medical therapy

CDC on Gastrointestinal perforation medical therapy

Gastrointestinal perforation medical therapy in the news

Blogs on Gastrointestinal perforation medical therapy

Directions to Hospitals Treating Stomach cancer

Risk calculators and risk factors for Gastrointestinal perforation medical therapy

Overview

Antibiotics 

Broad-spectrum antibiotic therapy is initiated if the level of perforation is unknown. The following tabel shows the regimens of choice in these cases:

Regimen Dose
First choice regimens
Ampicillin-sulbactam 3 g IV every six hours
Piperacillin-tazobactam 3.375 or 4.5 g IV every six hours
Ticarcillin-clavulanate 3.1 g IV every four hours
Ceftriaxone 1 g IV every 24 hours
Metronidazole 500 mg IV every eight hours
Alternative regimens
Ciprofloxacin 400 mg IV every 12 hours
Levofloxacin 500 or 750 mg IV once daily
Metronidazole 500 mg IV every eight hours
Imipenem-cilastatin 500 mg IV every six hours
Meropenem 1 g IV every eight hours
Doripenem 500 mg IV every eight hours
Ertapenem 1 g IV once daily

Intravenous fluid therapy

Dynamic measures for circulation

  • There is an evidence that dynamic measures are more accurate predictors of fluid responsiveness than static measures. These measures include:
  • Respiratory changes in the vena cava
  • Radial artery pulse pressure
  • Aortic blood flow peak velocity
  • Left ventricular outflow tract velocity-time integral
  • Brachial artery blood flow velocity are considered dynamic measures of fluid responsiveness
  • Serum lactate in patients with sepsis should be assessed until the lactate value has clearly fallen. [3]

Vasopressors

References